HAIs Greatly Increase the Length and Cost of Hospital Stays

Article

Adults who developed healthcare-associated infections (HAIs) due to medical or surgical care while in the hospital in 2007 had to stay an average of 19 days longer than adults who didn't develop an infection, (24 days versus five days), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

For patients with an HAI, the rate of death in the hospital, on average, was six times as high as the rate for patients without an HAI (9 percent versus 1.5 percent). Also, on average, the cost of a hospital stay of an adult patient who developed an HAI was about $43,000 more expensive than the stay of a patient without an HAI ($52,096 versus $9,377).

The federal agency also found that:

- In 2007, about 45 percent of patients with HAIs were 65 or older, 33 percent were 45 to 64 and 22 percent were ages 18 to 44. However, the 45- to 64-year-old group had the highest rate of HAIs.

- The top three diagnoses in hospitalized adult patients who developed HAIs were: septicemia (12 percent), adult respiratory failure (6 percent), and complications from surgical procedures or medical treatment (4 percent).

- The rate of infections among medical and surgical discharges peaked in 2004 and 2005 at 2.3 per 1000 stays, then declined to 2.03, a rate similar to year 2000.

This AHRQ News and Numbers is based on data in Adult Hospital Stays with Infection Due to Medical Care, 2007 (http://www.hcup-us.ahrq.gov/reports/statbriefs/sb94.pdf). The report uses statistics from the 2007 Nationwide Inpatient Sample, a database of hospital inpatient stays that is nationally representative of inpatient stays in all short-term, non-federal hospitals. The data are drawn from hospitals that comprise 90 percent of all discharges in the United States and include all patients, regardless of insurance type, as well as the uninsured.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.